首页> 外文会议>2012 Abstracts 39th IEEE International Conference on Plasma Science. >Inducing intracellular ros and cellular redox without cell death in mesenchymal cells using microsecondpulsed DBD plasma
【24h】

Inducing intracellular ros and cellular redox without cell death in mesenchymal cells using microsecondpulsed DBD plasma

机译:使用微秒脉冲DBD血浆诱导间充质细胞内细胞内ros和细胞氧化还原而无细胞死亡

获取原文
获取原文并翻译 | 示例

摘要

Intracellular reactive oxygen species (ROS) is a known activator of cell signaling, however too much ROS causes cell death. Our goal was to determine the optimal microsecond-pulsed Dielectric Barrier Discharge plasma (DBD-plasma) treatment dose (J/cm2) in which ROS/redox responses would potentially activate cell function but not cell death. In this study, we applied DBD-plasma to mesenchymal cells and evaluated intracellular ROS generation, redox, mitochondrial membrane potential and the Live/Dead response to increasing levels of DBD-plasma. Using fluorescent indicators to measure superoxide anion (O2.) (MitoSOX™ Red), reduced glutathione (GSH) (ThiolTracker™ Violet) and mitochondrial membrane potential (ΔΨm) (MitoTracker® Red), we show that DBD-plasma doses of 1–5 J/cm2 stimulated an immediate (minutes) increase in O2 levels with a concomitant decrease in reduced thiol. The mitosox fluorescence intensity increased with DBD-plasma treatments until 1 J/cm2, after which levels plateaued regardless of increased dose. Reduced thiol fluorescent intensity showed an immediate 50% decrease regardless of DBD-plasma treatment dose. A 20% decrease in mitochondrial membrane potential occurred at 2 hrs post-DBD-plasma treatments 1 – 5 J/cm2, with significant cell death observed (fluorescent Live/Dead assay; syto- 13/propidium iodide) at levels of 2.5 J/cm2 and greater. Taken together, these results provide a range in which DBD (0–2.0 J/cm2) intracellular ROS generation and cellular redox change with little effect on cell viability. Understanding the optimal treatment levels DBD-plasma interactions is essential for developing DBD-plasma treatments to induce directed cell function such as; proliferation, differentiation and targeted gene expression.
机译:细胞内活性氧(ROS)是细胞信号转导的已知激活剂,但是过多的ROS会导致细胞死亡。我们的目标是确定最佳的微秒脉冲介电屏障放电等离子体(DBD-plasma)治疗剂量(J / cm2),其中ROS /氧化还原反应可能会激活细胞功能,但不会激活细胞死亡。在这项研究中,我们将DBD血浆应用于间充质细胞,并评估了细胞内ROS的产生,氧化还原,线粒体膜电位以及对DBD血浆水平升高的活/死反应。使用荧光指示剂测量超氧阴离子(O2 -。)(MitoSOX™红色),还原型谷胱甘肽(GSH)(ThiolTracker™紫色)和线粒体膜电位(ΔΨm)(MitoTracker®红色) DBD血浆剂量为1–5 J / cm 2 刺激O2 -水平立即(分钟)增加,同时硫醇还原量减少。 DBD-血浆处理后,mitosox荧光强度增加,直到1 J / cm 2 ,此后无论剂量增加,其水平都达到稳定。硫醇荧光强度降低显示立即降低50%,无论DBD血浆治疗剂量如何。在DBD血浆处理1 – 5 J / cm 2 后2小时,线粒体膜电位降低了20%,观察到明显的细胞死亡(荧光活/死分析; syto-13 /丙啶)碘化物)的浓度为2.5 J / cm 2 或更高。两者合计,这些结果提供了一个范围,其中DBD(0–2.0 J / cm 2 )细胞内ROS的产生和细胞氧化还原的变化对细胞生存力的影响很小。了解最佳治疗水平DBD-血浆相互作用对于开发DBD-血浆治疗以诱导定向细胞功能至关重要,例如;增殖,分化和靶向基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号